X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs LUPIN - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH LUPIN STERLING BIOTECH/
LUPIN
 
P/E (TTM) x -0.4 46.6 - View Chart
P/BV x 0.0 2.9 0.5% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 STERLING BIOTECH   LUPIN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
LUPIN
Mar-18
STERLING BIOTECH/
LUPIN
5-Yr Chart
Click to enlarge
High Rs111,465 0.7%   
Low Rs3727 0.5%   
Sales per share (Unadj.) Rs26.8349.6 7.7%  
Earnings per share (Unadj.) Rs-15.05.6 -269.1%  
Cash flow per share (Unadj.) Rs-5.529.6 -18.5%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs54.9300.3 18.3%  
Shares outstanding (eoy) m267.87452.08 59.3%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x0.33.1 8.3%   
Avg P/E ratio x-0.5197.2 -0.2%  
P/CF ratio (eoy) x-1.337.1 -3.4%  
Price / Book Value ratio x0.13.6 3.5%  
Dividend payout %090.0 0.0%   
Avg Mkt Cap Rs m1,862495,502 0.4%   
No. of employees `0001.417.0 7.9%   
Total wages/salary Rs m54728,647 1.9%   
Avg. sales/employee Rs Th5,303.39,273.6 57.2%   
Avg. wages/employee Rs Th403.81,681.0 24.0%   
Avg. net profit/employee Rs Th-2,959.0147.4 -2,007.0%   
INCOME DATA
Net Sales Rs m7,181158,042 4.5%  
Other income Rs m431,504 2.8%   
Total revenues Rs m7,223159,545 4.5%   
Gross profit Rs m94731,475 3.0%  
Depreciation Rs m2,54310,859 23.4%   
Interest Rs m4,3772,044 214.2%   
Profit before tax Rs m-5,93120,076 -29.5%   
Minority Interest Rs m0-71 0.0%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m-1,9242,885 -66.7%   
Profit after tax Rs m-4,0072,513 -159.5%  
Gross profit margin %13.219.9 66.2%  
Effective tax rate %32.414.4 225.8%   
Net profit margin %-55.81.6 -3,509.5%  
BALANCE SHEET DATA
Current assets Rs m14,335122,095 11.7%   
Current liabilities Rs m49,80950,956 97.8%   
Net working cap to sales %-494.045.0 -1,097.5%  
Current ratio x0.32.4 12.0%  
Inventory Days Days40385 476.9%  
Debtors Days Days171120 142.3%  
Net fixed assets Rs m55,432129,876 42.7%   
Share capital Rs m268904 29.6%   
"Free" reserves Rs m13,935134,866 10.3%   
Net worth Rs m14,701135,771 10.8%   
Long term debt Rs m9,47864,245 14.8%   
Total assets Rs m73,988263,054 28.1%  
Interest coverage x-0.410.8 -3.3%   
Debt to equity ratio x0.60.5 136.2%  
Sales to assets ratio x0.10.6 16.2%   
Return on assets %0.51.7 28.9%  
Return on equity %-27.31.9 -1,472.6%  
Return on capital %-6.43.7 -172.7%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,86053,141 3.5%   
Fx outflow Rs m2519,335 0.1%   
Net fx Rs m1,83533,807 5.4%   
CASH FLOW
From Operations Rs m1,71917,512 9.8%  
From Investments Rs m-3,148-14,073 22.4%  
From Financial Activity Rs m1,426-14,921 -9.6%  
Net Cashflow Rs m-3-11,482 0.0%  

Share Holding

Indian Promoters % 33.9 46.6 72.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 9.9 31.9 31.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 10.1 389.1%  
Shareholders   21,482 98,259 21.9%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   AUROBINDO PHARMA  MERCK  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Lower; Banking and Automobile Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (4QFY18); Net Profit Down 305.5% (Quarterly Result Update)

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, LUPIN LTD has posted a net profit of Rs 8 bn (down 305.5% YoY). Sales on the other hand came in at Rs 40 bn (down 5.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - NOVARTIS COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS